Merck Animal Health, a division of Merck & Co. (MRK), agreed to acquire TARGAN, a privately held developer of biodevice solutions for the poultry industry, for undisclosed consideration. The deal expands Merck Animal Health's capabilities in poultry technology and reflects continued investment in animal health innovation. No financial terms were disclosed, limiting near-term valuation impact.
Merck Animal Health, a division of Merck & Co. (MRK), agreed to acquire TARGAN, a privately held developer of biodevice solutions for the poultry industry, for undisclosed consideration. The deal expands Merck Animal Health's capabilities in poultry technology and reflects continued investment in animal health innovation. No financial terms were disclosed, limiting near-term valuation impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
